| AbbVie AG - Rinvoq 30 mg, Retardtabletten | | 67257 | | 05 | | Rinvoq 30 mg | | Retardtabletten | | | | | | 07.06.2024 | | |
| | Composition | | upadacitinibum 30 mg ut upadacitinibum hemihydricum, cellulosum microcristallinum, hypromellosum, mannitolum, acidum tartaricum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Delayed release tablets | | | | | | BAG: Active Agent | Dose |
|---|
| | 30 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | Tartaric Acid | | | | | | | | | | color. | | | | color. | | Hypromellosum | | | | Macrogol | 3350 | | | | | | | Mannitol | | | | | | Überzug | | | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 28 | 765.24 | 848.65 | B | SL | No |
|
|
